exciting news from nadf

​April 25, 2020

​We would like to take this opportunity to make some exciting and important announcements. We have seen rapid growth of our foundation over the past decade or so, with the trajectory of growth in the responsibilities required to run NADF accelerating equally as quickly.

READ HERE

---

COVID-19 DOSING RECOMMENDATIONS 

For those with adrenal insufficiency and confirmed or suspected Covid-19, increase the dose of hydrocortisone to 20 mg every 6 hours until the fever subsides, and then go back to the usual double dose until completely better.

download Pdf

---

COVID-19 - ADRENAL INSUFFICIENCY AND STEROID DOSING GUIDELINES

April 10, 2020

• When individuals with adrenal insufficiency (AI) are not sick and therefore not requiring stress dosing, they should not be taking higher or lower doses of hydrocortisone hoping it will protect them from getting sick. 

Read Here

---

​ADRENAL INSUFFICIENCY STUDY EXPANDS TO COVID MONITORING

This pandemic is frightening for everyone, but particularly for those who have chronic medical conditions. Adrenal insufficient patients have twin risks of possibly “catching” COVID-19 more easily and the additional problem of adrenal crisis complicating their ability to respond to a major illness.

Read here

---

April 9, 2020

As a follow-up to our March 13th bulletin, we are sharing an update regarding the availability of hydrocortisone tablets. The NADF team continues to support our community by working with the FDA and pharmaceuticals regarding the issues our adrenal insufficiency patients have been experiencing with their difficulty filling this life-preserving drug.

Read Here

---

​CORONAVIRUS (COVID-19) UPDATE

​​On March 24th, The American Association of Clinical Endocrinologists (AACE) provided an important Coronavirus (COVID-19) position statement for people with Adrenal Insufficiency and Cushing’s Syndrome. You can read their statement here:

Read HERE

---

​UPDATE FROM NADF - KEEP A SUPPLY OF MEDS

March 13, 2020
​
During this unprecedented and stressful time as the world fends off COVID-19, NADF continues to support you. That said, this communication serves several purposes:

Read here

---

UPDATE ON RECENT NADF MEDICAL DIRECTOR’S STATEMENT

March 10, 2020

We’ve become aware of a study in the European Journal of Endocrinology. This is an important study and have an updated response from NADF Medical Director Paul Margulies, MD, FACE, FACP.

READ HERE

---

ADRENAL INSUFFICIENCY IN THE UNITED STATES 2019 PAPER

​Paper written by: Elizabeth A. Regan*, Anand Vaidya, Paul L. Margulies, Barry J. Make, Katherine E. Lowe and James D. Crapo

link to web page

---

DISASTER PREPAREDNESS GUIDELINES FOR PATIENTS WITH ADRENAL INSUFFICIENCY

Here are new guidelines,

Download PDF

---

NEW! EMERGENCY KIT FOR ADRENAL INSUFFICIENT PATIENts

Guidance on what should be included in the emergency kit , with instructions/quick reference on how to inject Solu Cortef.

Download PDF

---

​HOW TO ADMINISTER SOLU-CORTEF®

Via Intramuscular Injection Using The ACTO-VIAL® System

DOWNLOAD PDF